198 related articles for article (PubMed ID: 29871649)
1. MICMIC: identification of DNA methylation of distal regulatory regions with causal effects on tumorigenesis.
Tong Y; Sun J; Wong CF; Kang Q; Ru B; Wong CN; Chan AS; Leung SY; Zhang J
Genome Biol; 2018 Jun; 19(1):73. PubMed ID: 29871649
[TBL] [Abstract][Full Text] [Related]
2. Impact of Colon-Specific DNA Methylation-Regulated Gene Modules on Colorectal Cancer Patient Survival.
Yu H; Jiang W; Chen G; Yang F; Zhao X; Ji Z; Ni J; Fu Y; Chen F; Zhao B
Med Sci Monit; 2019 May; 25():3549-3557. PubMed ID: 31083646
[TBL] [Abstract][Full Text] [Related]
3. Elucidating the landscape of aberrant DNA methylation in hepatocellular carcinoma.
Song MA; Tiirikainen M; Kwee S; Okimoto G; Yu H; Wong LL
PLoS One; 2013; 8(2):e55761. PubMed ID: 23437062
[TBL] [Abstract][Full Text] [Related]
4. Integrated epigenomic analyses of enhancer as well as promoter regions in gastric cancer.
Baek SJ; Kim M; Bae DH; Kim JH; Kim HJ; Han ME; Oh SO; Kim YS; Kim SY
Oncotarget; 2016 May; 7(18):25620-31. PubMed ID: 27016420
[TBL] [Abstract][Full Text] [Related]
5. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
6. Enhancer methylation dynamics drive core transcriptional regulatory circuitry in pan-cancer.
Pan X; Li X; Sun J; Xiong Z; Hu H; Ning S; Zhi H
Oncogene; 2022 Jun; 41(26):3474-3484. PubMed ID: 35655092
[TBL] [Abstract][Full Text] [Related]
7. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
8. DNA methylation of distal regulatory sites characterizes dysregulation of cancer genes.
Aran D; Sabato S; Hellman A
Genome Biol; 2013 Mar; 14(3):R21. PubMed ID: 23497655
[TBL] [Abstract][Full Text] [Related]
9. Distinct epigenetic signatures elucidate enhancer-gene relationships that delineate CIMP and non-CIMP colorectal cancers.
Chong A; Teo JX; Ban KH
Oncotarget; 2016 May; 7(19):28027-39. PubMed ID: 27049830
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic analysis in the search for tumor suppressor genes.
Han ZG
Epigenomics; 2010 Aug; 2(4):489-93. PubMed ID: 22121966
[No Abstract] [Full Text] [Related]
11. Epigenomic analysis detects aberrant super-enhancer DNA methylation in human cancer.
Heyn H; Vidal E; Ferreira HJ; Vizoso M; Sayols S; Gomez A; Moran S; Boque-Sastre R; Guil S; Martinez-Cardus A; Lin CY; Royo R; Sanchez-Mut JV; Martinez R; Gut M; Torrents D; Orozco M; Gut I; Young RA; Esteller M
Genome Biol; 2016 Jan; 17():11. PubMed ID: 26813288
[TBL] [Abstract][Full Text] [Related]
12. Exploring breast carcinogenesis through integrative genomics and epigenomics analyses.
Minning C; Mokhtar NM; Abdullah N; Muhammad R; Emran NA; Ali SA; Harun R; Jamal R
Int J Oncol; 2014 Nov; 45(5):1959-68. PubMed ID: 25175708
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
Weisenberger DJ; Liang G; Lenz HJ
Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
[TBL] [Abstract][Full Text] [Related]
14. Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer.
Soozangar N; Sadeghi MR; Jeddi F; Somi MH; Shirmohamadi M; Samadi N
J Cell Physiol; 2018 May; 233(5):3968-3981. PubMed ID: 28888056
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic Changes of the ESR1 Gene in Breast Tissue of Healthy Women: A Missing Link with Breast Cancer Risk Factors?
Daraei A; Izadi P; Khorasani G; Nafissi N; Naghizadeh MM; Younosi N; Meysamie A; Mansoori Y; Bastami M; Tavakkoly-Bazzaz J
Genet Test Mol Biomarkers; 2017 Aug; 21(8):464-470. PubMed ID: 28708432
[TBL] [Abstract][Full Text] [Related]
16. Lineage-specific DNA methylation in T cells correlates with histone methylation and enhancer activity.
Schmidl C; Klug M; Boeld TJ; Andreesen R; Hoffmann P; Edinger M; Rehli M
Genome Res; 2009 Jul; 19(7):1165-74. PubMed ID: 19494038
[TBL] [Abstract][Full Text] [Related]
17. Improved regulatory element prediction based on tissue-specific local epigenomic signatures.
He Y; Gorkin DU; Dickel DE; Nery JR; Castanon RG; Lee AY; Shen Y; Visel A; Pennacchio LA; Ren B; Ecker JR
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):E1633-E1640. PubMed ID: 28193886
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide DNA methylation analysis of colorectal adenomas with and without recurrence reveals an association between cytosine-phosphate-guanine methylation and histological subtypes.
Fiedler D; Hirsch D; El Hajj N; Yang HH; Hu Y; Sticht C; Nanda I; Belle S; Rueschoff J; Lee MP; Ried T; Haaf T; Gaiser T
Genes Chromosomes Cancer; 2019 Nov; 58(11):783-797. PubMed ID: 31334584
[TBL] [Abstract][Full Text] [Related]
19. Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia.
Akalin A; Garrett-Bakelman FE; Kormaksson M; Busuttil J; Zhang L; Khrebtukova I; Milne TA; Huang Y; Biswas D; Hess JL; Allis CD; Roeder RG; Valk PJ; Löwenberg B; Delwel R; Fernandez HF; Paietta E; Tallman MS; Schroth GP; Mason CE; Melnick A; Figueroa ME
PLoS Genet; 2012; 8(6):e1002781. PubMed ID: 22737091
[TBL] [Abstract][Full Text] [Related]
20. Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter.
Poli E; Zhang J; Nwachukwu C; Zheng Y; Adedokun B; Olopade OI; Han YJ
PLoS One; 2015; 10(11):e0142224. PubMed ID: 26539832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
